Àç´Ü¼Ò°³
Àç´Ü»ç¾÷
º´¿ø¾àÇкаú
¾Ë¸²¸¶´ç
Ä¿¹Â´ÏƼ
º´¿ø¾à»çȸ
»ç¾÷¼Ò°³
ÀÚ·á½Ç
¿À½Ã´Â±æ
Smart Campus
º´¿ø¾àÇÐ ¿¬±¸³í¹® °Ë»ö
2009 ¤Ó ƯÁý
This study aimed to assess the cost effectiveness of pharmacistsintervention(improved dosing schedules: simplifying the regimen to daily dosing)to patientswith type 2 dibetes. From April to May 2010, 41 outpatients taking sulfonylurea as oralhypoglycemic agent in endocrine department of Seoul St. Mary Hospital were divided intotwo groups ; Group A kept taking sulfonylurea medication before meal while group Bchanged the time of administration to immediately after meal. After follow-up untilNovember 2010, changes in compliance on medication measured by Morisky's scale(6:low,6~7:medium, 8:high), HbA1C(%) and the cost were compared respectively. No significantdifferences in compliance, HbA1c and the cost were found between two groups. However,when the group B was divided into moderate compliance group(Morisky¡¯s scale¡Ã6) and poorcompliance group(Morisky¡¯s scale¡Â5), the compliance was significantly enhanced(1.3¡¾1.3vs. -0.5¡¾0.8 p=0.0001) in the poor compliance group while there was no significant difference in HbA1c. Although the effects of the improved medication compliance on glycemiccontrol and the cost were not clearly investigated in this study, the findings of this studyindicated that medication compliance was improved by simplifying the regimen especially in the patients with poor compliance from the initial state. Further research with expandedstudy period is needed to determine the effects of improved compliance on treatment outcome and the cost.